Skip to content

Effect of antiviral therapy on the prognosis of chronic hepatitis B carriers: an observational study based on liver histological examination

Effect of antiviral therapy on the prognosis of chronic hepatitis B carriers: an observational study based on liver histological examination

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2200058421
Enrollment
Unknown
Registered
2022-04-09
Start date
2022-06-01
Completion date
Unknown
Last updated
2024-01-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hepatitis B virus

Interventions

None listed

Sponsors

The Third Hosptial of Zhenjiang Affiliated Jiangsu University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
13 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Meet the diagnostic criteria of hepatitis B infection (records show that HBsAg is positive for more than 6 months, or confirmed by liver biopsy); 2. Liver function index represented by ALT is normal; 3. Liver pathology: G < 2 ; S < 2; 4. There are no clinical symptoms or signs related to hepatitis B.

Exclusion criteria

Exclusion criteria: 1. Dropped out and lost; 2. Those with abnormal liver function represented by ALT or clinical symptoms and signs related to hepatitis B during follow-up; 3. Complicated with malignant tumors and HIV infection; 4. Complicated with other liver diseases such as viral hepatitis, autoimmune liver disease, drug-induced liver disease, etc. 5. Clinical diagnosis of liver failure or decompensation of liver cirrhosis (grade Child-PughB, C, serious complications such as esophageal and gastric varices bleeding, hepatic encephalopathy, ascites and so on); 6. Clinical diagnosis of hepatocellular carcinoma or diagnosis of hepatocellular carcinoma or serum alpha-fetoprotein > 100 ug/L.

Design outcomes

Primary

MeasureTime frame
Liver function (ALT, AST);PLT;HBV-DNA;HBsAg;AFP;Liver Stiffness Measurement;Liver disease-related deaths;

Countries

China

Contacts

Public ContactTan Youwen

The Third Hosptial of Zhenjiang Affiliated Jiangsu University

tyw915@sina.com+86 13914567088

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026